Adverse events · postmenopausal women with osteoporosis and CKD stages 3‐4
Any anti‐osteoporotic drugs showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Death · postmenopausal women with osteoporosis and CKD stages 3‐4
1 finding from 1 review
QoL · postmenopausal women with osteoporosis and CKD stages 3‐4
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment responsea · children and young people with JIA
Methotrexate showed no clear difference in treatment responsea(4 months) compared with alternative disease‐modifying antirheumatic drugs (low certainty).
1 finding from 1 review
Serious adverse events attributable to the drug · people with confirmed COVID‐19
Favipiravir showed no clear difference in serious adverse events attributable to the drug compared with no treatment, supportive treatment, or other antiviral treatment (low certainty).
1 finding from 1 review
Treatment withdrawal · adults and children with drug‐resistant focal epilepsy
Any dose of lacosamide probably leads to higher treatment withdrawal compared with placebo (moderate certainty).
1 finding from 1 review
Frequency of drug use 12 months · Parents who use substances
2 findings from 1 review
Frequency of drug use 12 months · Parents who use substances
2 findings from 1 review
Proportion of children achieving 14 consecutive dry nights by the end of treatment · children with nocturnal enuresis
Alarm may leads to higher proportion of children achieving 14 consecutive dry nights by the… compared with placebo drug (low certainty).
1 finding from 1 review
Length of time to report TB drug susceptibility test results · health‐district‐wide electronic TB laboratory information system for improving the timeliness of test results and treatment in the TB…
Web‐based electronic TB laboratory information system probably leads to lower length of time to report TB drug susceptibility test results compared with a paper‐based system (moderate certainty).
1 finding from 1 review
Recording errors of TB drug susceptibility test results (Overall) · health‐district‐wide electronic TB laboratory information system for improving the timeliness of test results and treatment in the TB…
Web‐based electronic TB laboratory information system probably leads to lower recording errors of TB drug susceptibility test results (Overall) compared with a paper‐based system (moderate certainty).
1 finding from 1 review
Recording errors: misidentification errors for TB drug susceptibility test resultse · health‐district‐wide electronic TB laboratory information system for improving the timeliness of test results and treatment in the TB…
It is very uncertain whether web‐based electronic TB laboratory information system changes recording errors: misidentification errors for TB drug… compared with a paper‐based system (very low certainty).
1 finding from 1 review
OR 1.1 [0.46, 2.63]
1 study · 1 participants
Very low
Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Microbial resistance to prophylactic drug: unit of analysis (UTI) · primary VUR
Antibiotic prophylaxis probably leads to higher microbial resistance to prophylactic drug: unit of analysis (UTI) compared with surveillance or no treatment (moderate certainty).
1 finding from 1 review
Time on allocated treatment (retention time) · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Retention [ · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
Clobazam may leads to higher retention at 6 months (measured by the number of treatment failures… compared with phenytoin (low certainty).
1 finding from 1 review
Economic outcomes: Costs due to treatment, as defined by each study (long term) · patients with schizophrenia
1 finding from 1 review
Efficacy: change in scores from baseline to endpoint (12 weeks) on symptom rating scales in the treatment of manic and mixed episodes Lower scores indicate improvement · adults with acute affective episodes in bipolar disorder
1 finding from 1 review
Change in depressive symptoms · adults with acute affective episodes in bipolar disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Response to treatment with topiramate. Number of participants experiencing a 50% reduction or greater in mean score from baseline to end of treatment on symptom rating scales in manic and mixed episodes · adults with acute affective episodes in bipolar disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found